Zydus Healthcare Buys 2 New Drug Applications From Teva

New Delhi: Zydus Healthcare, a subsidiary of Cadila Healthcare, on Monday said it has acquired two abbreviated new drug applications (ANDAs) from Teva Pharmaceutical in the US for an undisclosed sum. "Zydus has strengthened its US portfolio with the acquisition of two ANDAs from Teva that are being divested by Teva as a pre-condition to its acquisition of Allergan's generic business," Cadila Healthcare said in a BSE filing. It furt...